John Edward Park,Gerald Juergen Roth,Armin Heckel,Nveed Chaudhary,Trixi Brandl,Georg Dahmann,Matthias Grauert
申请号：
US14982179
公开号：
US10154990B2
申请日:
2015.12.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the use of indolinones of general formulasubstituted in the 6 position, whereinR1 to R5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.
